ARCHIVES

Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs

This article is from The Cancer Letter archive.

Vol. 04 No. 36 | September 8, 1978

Download PDF Visit The Full Archive

Related Articles

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

Sentinel Node Disection No Worse Than Axillary

February 25, 2011